CARTER TODD ALFRED (Chief Scientific Officer) sold 4.3% of their position (3.97K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $29.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/22/2024ACC: 0001104659-24-026554
Officer· Chief Scientific Officer
Since Feb 2026
-3.97K
Net shares
Net seller
$29.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.97K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−602.00
Price / share
$7.68
Trade value
$4.62K
% of position
0.7%
2/20/2024
91.59K→90.99K
Common Stock
Direct
Shares
−3.37K
Price / share
$7.47
Trade value
$25.14K
% of position
3.7%
2/21/2024
90.99K→87.63K
Total
Net shares
−3.97K
Net value
-$29.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2024 | S · Sale | −602.00 | $7.68 | $4.62K | 0.7% | 91.59K | 90.99K |
| Common Stock Direct | 2/21/2024 | S · Sale | −3.37K | $7.47 | $25.14K | 3.7% | 90.99K | 87.63K |
| Total | −3.97K | -$29.76K | ||||||
Derivative Transactions0
No derivative transactions reported